Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01876914 · ClinicalTrials.gov registry record

Pilot Study of OCT Versus Fluorescein Angiography in DME

A clinical trial, sponsored by Oregon Health and Science University.

Completed
Registry status
20
Enrollment target

NCT01876914 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01876914 has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

Diabetic Macular Edema (DME), which can happen as a complication of diabetes, occurs when fluid and proteins collect in the macula (the yellow central area of the retina). The fluid can cause swelling which in turn can lead to worsening central vision. The purpose of this study is to see if the study device (Swept Source Optical Coherence Tomography or SS-OCT) is able to diagnose DME as well as an already approved imaging procedure called fluorescein angiography (FA). FA is standard of care and would be conducted regardless of study participation. The dye used in FA, which can cause allergic reactions in some patients and is not used in pregnant women, is not needed with the study device. Another purpose of the study is to avoid the risk of administering the FA dye if possible.

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2013-06
Est. Completion 2017-12-23

What the Registry Record Tells You About NCT01876914

The ClinicalTrials.gov registry entry for NCT01876914 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01876914 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01876914 about?

NCT01876914 is a clinical study titled "Pilot Study of OCT Versus Fluorescein Angiography in DME". Diabetic Macular Edema (DME), which can happen as a complication of diabetes, occurs when fluid and proteins collect in the macula (the yellow central area of the retina). The fluid can cause swelling which in turn can lead to worsening central vision. The purpose of this study is to see if the stud...

What is the current status of trial NCT01876914?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2013-06. Estimated completion is 2017-12-23.

Who is sponsoring clinical trial NCT01876914?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.